Genetic selection of poliovirus 2A(pro)-binding peptides

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 814-818

  Ventoso, Iván ^a   Barco, Angel ^a   Carrasco, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR; PROTEINASE; VIRUS ENZYME;

AMINO ACID SEQUENCE; ARTICLE; ENZYME INDUCTION; HELA CELL; MOLECULAR CLONING; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; TRANSCRIPTION INITIATION;

EID: 0032889317     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.814-818.1999     Document Type: Article

References (28)

1. Aelst, L. V. M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between Ras and Raf and other protein kinases. Proc. Natl. Acad. Sci. USA 90:6213-6217.
2. Barco, A., I. Ventoso, and L. Carrasco. 1997. The yeast Saccharomyces cerevisiae as a genetic system for obtaining variants of poliovirus protease 2A*. J. Biol. Chem. 272:12683-12691.
3. Bazan, J. F., and R. J. Fletterick. 1988. Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc. Natl. Acad. Sci. USA 85:7872-7876.
4. Berger, A., and I. Schechter. 1970. Mapping the active site of papain with the aid of peptide substrates and inhibitors. Phil. Trans. R. Soc. Lond. B 257:249-264.
5. Bovee, L. M., B. J. Lamphear, R. E. Rhoads, and R. Lloyd. 1998. Direct cleavage of eIF-4G by poliovirus 2A protease is inefficient in vitro. Virology 245:241-249.
6. pro on cellular metabolism. J. Biol. Chem. 266:14714-14720.
7. Dreyer, G. B., B. W. Metcalf, T. A. Tamaszek, Jr, T. J. Carr, A. C. Chandler III, L. Hyland, S. A. Fakhoury, V. W. Magaard, M. L. Moore, J. E. Strickler, C. Debouck, and T. D. Meek. 1989. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. Proc. Natl. Acad. Sci. USA 86:9752-9756.
8. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-246.
9. Fields, S., and R. Sternglanz. 1994. The two-hybrid system: an assay for protein-protein interactions. Trends Genet. 10:286-291.
10. Gietz, D., A. St. Jean, R. A. Woods, and R. H. Shiestl. Improved method for high efficiency transformation of intact yeast cells. 1992. Nucleic Acids Res. 20:1425.
11. Hambidge, S. J., and P. Sarnow. 1992. Translational enhancement of the poliovirus 5′ noncoding region mediated by virus-encoded polypeptide 2A. Proc. Natl. Acad. Sci. USA 89:10272-10276.
12. Hellen, C. U. T., M. Fäcke, H. Kräusslich, C. Lee, and E. Wimmer. 1991. Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220. J. Virol. 65:4226-4231.
13. Hellen, C. U. T., C.-K. Lee, and E. Wimmer. 1992. Determinants of substrate recognition by poliovirus 2A proteinase. J. Virol. 66:3330-3338.
14. Krausslich, H. G., M. J. Nicklin, H. Toyoda, D. Etchison, and E. Wimmer. 1987. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J. Virol. 61:2711-2718.
15. Lamphear, B. J., R. Yan, F. Yang, D. Waters, H.-D. Liebig, H. Klump, E. Kuechler, T. Skern, and R. E. Rhoads. 1993. Mapping the cleavage site in protein synthesis initiation factor eIF-4G gamma of the 2A proteases from human coxsackievirus and rhinovirus. J. Biol. Chem. 268:19200-19203.
16. pro-mediated, alternative cleavage of polypeptide 3CD by in vitro mutagenesis. Virology 166:405-414.
17. Li, B., and S. Fields. 1993. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system. FASEB J. 7:957-963.
18. Meek, T. D., D. M. Lambert, G. B. Dreyer, T. J. Carr, T. A. Tomaszek, Jr., M. L. Moore, J. E. Strickler, C. Debouck, L. J. Hyland, T. J. Matthews, B. W. Metcalf, and S. R. Petteway. 1990. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues. Nature 343:90-92.
19. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
20. Molla, A., C. U. T. Hellen, and E. Wimmer. 1993. Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. J. Virol. 67:4688-4695.
21. pro in RNA replication. Virology 196:739-747.
22. pro in cell-free systems. Effects on translation of capped and uncapped mRNAs. Biochemistry 36:7802-7809.
23. Palmenberg, A. 1990. Proteolytic processing of picomaviral polyprotein. Annu. Rev. Microbiol. 44:603-623.
24. Roberts, L. B., W. Markland, C. A. Ley, B. R. Kent, W. D. White, K. S. Guterman, and C. R. Ladner. 1992. Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M18 fusion phase. Proc. Natl. Acad. Sci. USA 89:2429-2433.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
26. Sommergruber, W., H. Ahorn, A. Zöphel, I. Maurer-Fogy, F. Fessl, G. Schnorrenberg, H.-D. Liebig, D. Blaas, E. Kuechler, and T. Skern. 1992. Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A. J. Biol. Chem. 267:22639-22644.
27. Toyoda, H., M. J. Nicklin, M. G. Murray, C. W. Anderson, J. J. Dunn, F. W. Studier, and E. Wimmer. 1986. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761-770.
28. pro mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects. J. Virol. 69:6280-6288.